RxDoctor Payments DataLook up a doctor →

Brian Heaton, MD

Urology · Ogden, UTNPI 1245248236

Payments from drug & device makers

$6,415in general payments, 2019–2025

Across 234 payments — averaging $27.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neotract Inc.$1K
  • Boston Scientific$1K
  • Astellas Pharma US Inc$449
  • Procept Biorobotics Corporation$405
  • Endo Pharmaceuticals Inc.$341
  • 180 Medical, Inc.$313
  • plus $2K from 45 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Neotract Inc.12$1,330
Boston Scientific30$1,088
Astellas Pharma US Inc21$449
Procept Biorobotics Corporation7$405
Endo Pharmaceuticals Inc.22$341
180 Medical, Inc.15$313
Pfizer16$275
Sumitomo Pharma America, Inc.8$159
Travere Therapeutics, Inc.8$153
Teleflex LLC8$146
Biocompatibles, Inc.1$107
Laborie Medical Technologies Corp.3$103
Endo USA, Inc.6$101
Comsort, Inc1$100
Amgen5$86
Coloplast5$86
AbbVie5$85
Johnson & Johnson5$80
AstraZeneca4$70
Myovant Sciences Inc.4$68
Ferring Pharmaceuticals Inc.4$66
Urogen Pharma, Inc.2$65
Axonics, Inc.2$53
Myriad Genetic Laboratories, Inc.4$51
Medtronic2$48
Dendreon Pharmaceuticals LLC2$45
Urovant Sciences Inc2$40
ABC Home Medical Supply, Inc.2$34
Therapeuticsmd, Inc.2$32
Convatec Inc.2$31
Verity Pharmaceuticals Inc.2$31
Cycle Pharmaceuticals Inc1$29
Polynovo North America LLC2$29
Covidien LP1$29
Antares Pharma, Inc.2$27
Duchesnay USA Incorporated1$25
Progenics Pharmaceuticals, Inc.1$21
Hollister Incorporated1$20
Blue Earth Diagnostics1$17
Photocure Inc1$17
Alnylam Pharmaceuticals Inc.1$17
Novartis1$16
Solventum Corporation1$15
Stryker1$15
Bayer1$14
Olympus America Inc.1$14
Valencia Technologies Corporation1$14
Conmed Corporation1$14
Merck1$13
Agiliti Surgical, Inc.1$13
Paratek Pharmaceuticals, Inc.1$12

How this compares

$6,415 in reported general payments places this provider in the 60th percentile of 96 urology providers in Utah.

See all urology providers in Utah →

Medicare billing

Part B allowed, 2024
$317,449
Medicare patients
727
Services billed
5,540

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Ogden

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →